DUBLIN--(BUSINESS WIRE)--The "Global Human Microbiome Market Analysis 2021-2031" report has been added to ResearchAndMarkets.com's offering.

The global human microbiome market is anticipated to grow with a CAGR of 22.3% over the forecast period, i.e., 2022 - 2031.

Factors such as the growing focus on microbiome therapeutics, followed by the surge in prevalence of lifestyle-related diseases, and the increasing research and developments on human microbiome are projected to add to the growth of the market in the coming years. The market is estimated to garner a revenue of near to USD 3250 Million by the end of 2031, up from a revenue of close to USD 440 Million in the year 2021.

The global human microbiome market is segmented by numerous segments which include segmentation by product, disease type, organism type, application, technology, and by region. By product, the market is segmented into probiotics, prebiotics, diagnostic tests, drugs, and others. By the end of 2031, the probiotics segment is anticipated to garner the largest revenue of about USD 1430 Million by the end of 2031. Additionally, in the year 2021, the segment generated a revenue of around USD 190 Million.

On the basis of regional analysis, the global human microbiome market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America, out of the market in all the other regions, is anticipated to garner the largest revenue of near to USD 1860 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of more than USD 250 Million.

However, the stringent government regulations is expected to operate as key restraint to the growth of global human microbiome market over the forecast period.

Companies Mentioned

• Seres Therapeutics Inc.
• Evelo Biosciences Inc.
• Synlogic
• SECOND GENOME
• Synthetic Biologics Inc.
• YSOPIA Bioscience
• 4D pharma plc
• DuPont de Nemours Inc.
• BiomX Inc.
• Sun Genomics Inc.
• Viome Life Sciences Inc.

Key Topics Covered:

1. Market Definition

2. Assumptions & Acronyms

3. Research Methodology

4. Executive Summary

5. Market Dynamics

6. Value Chain Analysis

7. Regulatory & Standards Landscape

8. Industry Risk Analysis

9. Impact of COVID-19 on the Human Microbiome Market

10. Analysis of Upcoming Human Microbiome Projects

11. Analysis of Therapeutic Products

11.1. Product Type

11.2. Pros

11.3. Cons

12. Pipeline Analysis

13. Analysis on Skin Microbiome-Focused Products

14. Product Feature Analysis

15. Competitive Landscape

16. Global Human Microbiome Market

17. North America Human Microbiome Market

18. Europe Human Microbiome Market

19. Asia Pacific Human Microbiome Market

20. Latin America Human Microbiome Market

21. Middle East & Africa Human Microbiome Market

For more information about this report visit

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900